Electrical Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
NVT vs ETN vs EMR vs ROK vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Conglomerates
NVT vs ETN vs EMR vs ROK vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Conglomerates |
| Market Cap | $26.96B | $155.02B | $79.02B | $50.37B | $136.91B |
| Revenue (TTM) | $4.33B | $28.52B | $18.32B | $8.80B | $36.76B |
| Net Income (TTM) | $492M | $3.99B | $2.44B | $1.09B | $4.10B |
| Gross Margin | 37.0% | 36.9% | 52.7% | 52.5% | 36.9% |
| Operating Margin | 15.8% | 18.1% | 19.8% | 19.1% | 14.9% |
| Forward P/E | 39.7x | 30.0x | 21.7x | 36.9x | 20.5x |
| Total Debt | $1.56B | $11.17B | $13.76B | $3.65B | $34.58B |
| Cash & Equiv. | $238M | $622M | $1.54B | $468M | $12.49B |
NVT vs ETN vs EMR vs ROK vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| nVent Electric plc (NVT) | 100 | 909.6 | +809.6% |
| Eaton Corporation p… (ETN) | 100 | 470.2 | +370.2% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Rockwell Automation… (ROK) | 100 | 207.4 | +107.4% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NVT vs ETN vs EMR vs ROK vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NVT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 29.5%, EPS growth 118.8%, 3Y rev CAGR 19.3%
- 29.5% revenue growth vs ROK's 1.0%
- +178.6% vs HON's +2.8%
ETN ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 6.1% 10Y total return vs NVT's 5.8%
- Lower volatility, beta 1.42, Low D/E 57.4%, current ratio 1.32x
- PEG 1.22 vs HON's 11.18
- 14.0% margin vs HON's 11.2%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
ROK is the clearest fit if your priority is efficiency.
- 9.7% ROA vs HON's 5.3%, ROIC 15.1% vs 12.6%
HON carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Lower P/E (20.5x vs 36.9x)
- Beta 0.74 vs NVT's 1.68
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% revenue growth vs ROK's 1.0% | |
| Value | Lower P/E (20.5x vs 36.9x) | |
| Quality / Margins | 14.0% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs NVT's 1.68 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +178.6% vs HON's +2.8% | |
| Efficiency (ROA) | 9.7% ROA vs HON's 5.3%, ROIC 15.1% vs 12.6% |
NVT vs ETN vs EMR vs ROK vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NVT vs ETN vs EMR vs ROK vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 1 of 6 categories
HON leads 1 • ROK leads 1 • NVT leads 1 • ETN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 8.5x NVT's $4.3B. Profitability is closely matched — net margins range from 14.0% (ETN) to 11.2% (HON). On growth, NVT holds the edge at +53.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.3B | $28.5B | $18.3B | $8.8B | $36.8B |
| EBITDAEarnings before interest/tax | $848M | $5.9B | $4.7B | $1.9B | $6.5B |
| Net IncomeAfter-tax profit | $492M | $4.0B | $2.4B | $1.1B | $4.1B |
| Free Cash FlowCash after capex | $387M | $4.7B | $3.1B | $1.3B | $4.2B |
| Gross MarginGross profit ÷ Revenue | +37.0% | +36.9% | +52.7% | +52.5% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +15.8% | +18.1% | +19.8% | +19.1% | +14.9% |
| Net MarginNet income ÷ Revenue | +11.4% | +14.0% | +13.3% | +12.4% | +11.2% |
| FCF MarginFCF ÷ Revenue | +8.9% | +16.5% | +17.0% | +15.2% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +53.5% | +16.8% | +2.9% | +11.8% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -59.7% | -9.4% | +28.2% | +39.6% | -41.9% |
Valuation Metrics
HON leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.4x trailing earnings, HON trades at a 50% valuation discount to ROK's 58.5x P/E. Adjusting for growth (PEG ratio), ETN offers better value at 1.55x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $27.0B | $155.0B | $79.0B | $50.4B | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $28.3B | $165.6B | $91.2B | $53.6B | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 38.68x | 38.17x | 34.92x | 58.45x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 39.70x | 30.00x | 21.71x | 36.93x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.55x | 7.73x | — | 15.99x |
| EV / EBITDAEnterprise value multiple | 34.30x | 27.69x | 18.07x | 30.64x | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 6.93x | 5.65x | 4.39x | 6.04x | 3.66x |
| Price / BookPrice ÷ Book value/share | 7.36x | 7.99x | 3.94x | 13.66x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 72.49x | 34.67x | 29.63x | 37.09x | 25.39x |
Profitability & Efficiency
ROK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $12 for EMR. NVT carries lower financial leverage with a 0.42x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs HON's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.4% | +20.8% | +12.1% | +29.6% | +23.1% |
| ROA (TTM)Return on assets | +7.2% | +9.0% | +5.8% | +9.7% | +5.3% |
| ROICReturn on invested capital | +8.9% | +13.6% | +8.2% | +15.1% | +12.6% |
| ROCEReturn on capital employed | +10.5% | +16.8% | +10.0% | +18.5% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 7 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.42x | 0.57x | 0.68x | 0.98x | 2.24x |
| Net DebtTotal debt minus cash | $1.3B | $10.5B | $12.2B | $3.2B | $22.1B |
| Cash & Equiv.Liquid assets | $238M | $622M | $1.5B | $468M | $12.5B |
| Total DebtShort + long-term debt | $1.6B | $11.2B | $13.8B | $3.6B | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 6.61x | 16.38x | 6.46x | 9.06x | 3.92x |
Total Returns (Dividends Reinvested)
NVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVT five years ago would be worth $53,671 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, NVT leads with a +178.6% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors NVT at 59.8% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +56.5% | +22.3% | +4.3% | +12.8% | +10.9% |
| 1-Year ReturnPast 12 months | +178.6% | +33.2% | +30.4% | +60.2% | +2.8% |
| 3-Year ReturnCumulative with dividends | +308.2% | +141.3% | +75.9% | +65.0% | +16.2% |
| 5-Year ReturnCumulative with dividends | +436.7% | +182.8% | +59.5% | +74.6% | +3.3% |
| 10-Year ReturnCumulative with dividends | +576.7% | +608.7% | +206.6% | +341.0% | +135.1% |
| CAGR (3Y)Annualised 3-year return | +59.8% | +34.1% | +20.7% | +18.2% | +5.1% |
Risk & Volatility
Evenly matched — ROK and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than NVT's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 96.7% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 1.42x | 1.52x | 1.33x | 0.74x |
| 52-Week HighHighest price in past year | $174.50 | $435.43 | $165.15 | $463.49 | $248.18 |
| 52-Week LowLowest price in past year | $59.73 | $296.93 | $108.37 | $277.66 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +91.7% | +85.4% | +96.7% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 82.3 | 59.8 | 61.3 | 74.9 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 2.5M | 2.8M | 831K | 3.7M |
Analyst Outlook
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NVT as "Buy", ETN as "Buy", EMR as "Buy", ROK as "Hold", HON as "Buy". Consensus price targets imply 14.8% upside for EMR (target: $162) vs -19.6% for NVT (target: $134). For income investors, HON offers the higher dividend yield at 2.14% vs NVT's 0.48%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $134.00 | $379.78 | $161.92 | $436.56 | $243.83 |
| # AnalystsCovering analysts | 17 | 39 | 41 | 39 | 28 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.0% | +1.5% | +1.2% | +2.1% |
| Dividend StreakConsecutive years of raises | 2 | 24 | 37 | 20 | 15 |
| Dividend / ShareAnnual DPS | $0.79 | $4.17 | $2.10 | $5.23 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.9% | +1.2% | +1.6% | +0.8% | +2.8% |
EMR leads in 1 of 6 categories (Income & Cash Flow). HON leads in 1 (Valuation Metrics). 2 tied.
NVT vs ETN vs EMR vs ROK vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NVT or ETN or EMR or ROK or HON a better buy right now?
For growth investors, nVent Electric plc (NVT) is the stronger pick with 29.
5% revenue growth year-over-year, versus 1. 0% for Rockwell Automation, Inc. (ROK). Honeywell International Inc. (HON) offers the better valuation at 29. 4x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate nVent Electric plc (NVT) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NVT or ETN or EMR or ROK or HON?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 4x versus Rockwell Automation, Inc. at 58. 5x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Eaton Corporation plc wins at 1. 22x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NVT or ETN or EMR or ROK or HON?
Over the past 5 years, nVent Electric plc (NVT) delivered a total return of +436.
7%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: ETN returned +608. 7% versus HON's +135. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NVT or ETN or EMR or ROK or HON?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus nVent Electric plc's 1. 68β — meaning NVT is approximately 126% more volatile than HON relative to the S&P 500. On balance sheet safety, nVent Electric plc (NVT) carries a lower debt/equity ratio of 42% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NVT or ETN or EMR or ROK or HON?
By revenue growth (latest reported year), nVent Electric plc (NVT) is pulling ahead at 29.
5% versus 1. 0% for Rockwell Automation, Inc. (ROK). On earnings-per-share growth, the picture is similar: nVent Electric plc grew EPS 118. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, NVT leads at 19. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NVT or ETN or EMR or ROK or HON?
nVent Electric plc (NVT) is the more profitable company, earning 18.
2% net margin versus 10. 4% for Rockwell Automation, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 15. 8% for NVT. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NVT or ETN or EMR or ROK or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Eaton Corporation plc (ETN) is the more undervalued stock at a PEG of 1. 22x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 5x forward P/E versus 39. 7x for nVent Electric plc — 19. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.
08Which pays a better dividend — NVT or ETN or EMR or ROK or HON?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 5% for nVent Electric plc (NVT).
09Is NVT or ETN or EMR or ROK or HON better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). nVent Electric plc (NVT) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +135. 1%, NVT: +576. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NVT and ETN and EMR and ROK and HON?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NVT is a mid-cap high-growth stock; ETN is a mid-cap quality compounder stock; EMR is a mid-cap quality compounder stock; ROK is a mid-cap quality compounder stock; HON is a mid-cap quality compounder stock. ETN, EMR, ROK, HON pay a dividend while NVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.